Jasna Metovic, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Neuroendocrine | 9 | 2023 | 346 | 4.320 |
Why?
|
Neuroendocrine Tumors | 9 | 2023 | 650 | 3.290 |
Why?
|
Lung Neoplasms | 11 | 2022 | 13262 | 1.150 |
Why?
|
Carcinoid Tumor | 4 | 2021 | 228 | 1.120 |
Why?
|
Thyroid Neoplasms | 5 | 2023 | 2332 | 0.830 |
Why?
|
Oxyphil Cells | 1 | 2020 | 57 | 0.720 |
Why?
|
Carcinoma, Large Cell | 1 | 2021 | 113 | 0.710 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2020 | 325 | 0.700 |
Why?
|
Giant Cell Tumors | 1 | 2020 | 90 | 0.690 |
Why?
|
Acrospiroma | 1 | 2019 | 12 | 0.660 |
Why?
|
Adenoma, Oxyphilic | 1 | 2020 | 148 | 0.650 |
Why?
|
Carcinoma in Situ | 2 | 2024 | 796 | 0.650 |
Why?
|
Repressor Proteins | 4 | 2022 | 2981 | 0.610 |
Why?
|
Nipples | 2 | 2019 | 221 | 0.600 |
Why?
|
Carcinoma, Papillary | 1 | 2023 | 785 | 0.590 |
Why?
|
Artifacts | 3 | 2021 | 1898 | 0.590 |
Why?
|
Neuroblastoma | 2 | 2023 | 1252 | 0.590 |
Why?
|
Sweat Gland Neoplasms | 1 | 2019 | 117 | 0.570 |
Why?
|
Breast Neoplasms | 9 | 2023 | 21025 | 0.570 |
Why?
|
Carcinoma, Lobular | 1 | 2021 | 489 | 0.550 |
Why?
|
Specimen Handling | 1 | 2021 | 707 | 0.530 |
Why?
|
Cytodiagnosis | 1 | 2019 | 442 | 0.490 |
Why?
|
Lung | 5 | 2021 | 9994 | 0.490 |
Why?
|
Immunity | 1 | 2020 | 998 | 0.480 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11071 | 0.440 |
Why?
|
Pancreatic Neoplasms | 4 | 2024 | 5351 | 0.410 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2532 | 0.370 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8056 | 0.310 |
Why?
|
Adenoma | 1 | 2019 | 2148 | 0.310 |
Why?
|
Prognosis | 10 | 2023 | 29658 | 0.270 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2873 | 0.200 |
Why?
|
Humans | 39 | 2024 | 760621 | 0.200 |
Why?
|
Receptors, Androgen | 2 | 2018 | 1077 | 0.200 |
Why?
|
Receptors, Estrogen | 3 | 2019 | 2210 | 0.200 |
Why?
|
Struma Ovarii | 1 | 2020 | 11 | 0.180 |
Why?
|
Receptor, Notch1 | 1 | 2022 | 495 | 0.170 |
Why?
|
Choristoma | 1 | 2021 | 207 | 0.170 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11152 | 0.170 |
Why?
|
Italy | 1 | 2021 | 841 | 0.160 |
Why?
|
Transcription Factors | 4 | 2022 | 12103 | 0.160 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 129 | 0.160 |
Why?
|
Adrenal Glands | 1 | 2021 | 554 | 0.160 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 416 | 0.160 |
Why?
|
Hedgehog Proteins | 1 | 2023 | 769 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 311 | 0.150 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.150 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2018 | 165 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 370 | 0.150 |
Why?
|
Microarray Analysis | 1 | 2020 | 747 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1155 | 0.150 |
Why?
|
Pleural Effusion, Malignant | 1 | 2018 | 103 | 0.150 |
Why?
|
Ki-67 Antigen | 1 | 2019 | 631 | 0.150 |
Why?
|
Membrane Proteins | 3 | 2022 | 7850 | 0.140 |
Why?
|
Sputum | 1 | 2019 | 503 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 2018 | 247 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1139 | 0.130 |
Why?
|
Amyloid | 1 | 2021 | 842 | 0.130 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 274 | 0.130 |
Why?
|
DNA Helicases | 1 | 2021 | 854 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3618 | 0.130 |
Why?
|
Middle Aged | 15 | 2023 | 220352 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2021 | 897 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2021 | 58995 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2022 | 80372 | 0.120 |
Why?
|
Fatty Liver | 1 | 2020 | 778 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1110 | 0.110 |
Why?
|
Breast | 1 | 2023 | 1963 | 0.110 |
Why?
|
Thymus Gland | 1 | 2018 | 1247 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4107 | 0.110 |
Why?
|
Bronchoscopy | 1 | 2019 | 911 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 2913 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1724 | 0.100 |
Why?
|
Female | 19 | 2023 | 391270 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2020 | 2299 | 0.090 |
Why?
|
Up-Regulation | 1 | 2020 | 4122 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1423 | 0.090 |
Why?
|
Trans-Activators | 1 | 2019 | 2860 | 0.080 |
Why?
|
Bone and Bones | 1 | 2020 | 2560 | 0.080 |
Why?
|
Aged | 9 | 2021 | 169152 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2325 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10182 | 0.080 |
Why?
|
Genomics | 2 | 2021 | 5794 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5961 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5791 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14660 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18137 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2022 | 11481 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9276 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15289 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8515 | 0.060 |
Why?
|
Adult | 9 | 2021 | 219994 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20080 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9411 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3790 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12965 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4878 | 0.050 |
Why?
|
Male | 10 | 2021 | 359744 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9585 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2022 | 26181 | 0.050 |
Why?
|
Caloric Restriction | 1 | 2023 | 296 | 0.050 |
Why?
|
Animals | 2 | 2024 | 167963 | 0.050 |
Why?
|
Janus Kinase 3 | 1 | 2020 | 77 | 0.040 |
Why?
|
Activating Transcription Factor 2 | 1 | 2020 | 45 | 0.040 |
Why?
|
Mutation | 3 | 2021 | 29932 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39261 | 0.040 |
Why?
|
Activin Receptors, Type II | 1 | 2020 | 124 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6828 | 0.040 |
Why?
|
Neoplasms | 2 | 2018 | 22072 | 0.040 |
Why?
|
Geography | 1 | 2020 | 661 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 555 | 0.040 |
Why?
|
Receptor, erbB-2 | 2 | 2019 | 2554 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.040 |
Why?
|
Child | 2 | 2022 | 79806 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 503 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 518 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3616 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1998 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 87810 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1130 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2828 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2020 | 1168 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2698 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1832 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22053 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1089 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 1056 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1052 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1745 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6315 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2821 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3486 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2020 | 2907 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1596 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3615 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2020 | 2053 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5643 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4713 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2023 | 16939 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6898 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6771 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10181 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12531 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15687 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10446 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4024 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8950 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13981 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65017 | 0.010 |
Why?
|